Literature DB >> 1304170

Intra-individual variability of caffeine elimination in healthy subjects.

A Balogh1, S Harder, R Vollandt, A H Staib.   

Abstract

Caffeine is a popular test substance for assessing the activity of hepatic drug metabolizing enzymes in vivo and in vitro. A correct estimation of the relative magnitudes of intra-individual and inter-individual variations in caffeine elimination is significant for the use of the elimination parameter of caffeine to characterize the biotransformation capacity of a specific form of cytochrome P-450 (1AII) in vivo. The purpose of this study is to demonstrate the magnitudes of fluctuation of caffeine-clearance and half-life as well as inter- and intra-individual comparison in 12 healthy male subjects. Compared to the high reproducibility of caffeine decay curves in each healthy male, caffeine elimination varied more extensively between subjects. The distribution of variance amounted to: intra-individual 21.4%, inter-individual 78.6%. The knowledge of variance provided precise evidence of the sample size, which is necessary to prove previously defined differences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304170

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  15 in total

Review 1.  The impact of caffeine on vasodilator stress perfusion studies.

Authors:  Andre C Lapeyre; Tauqir Y Goraya; Donald L Johnston; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

2.  Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis.

Authors:  Joseph C Lee; John F Fraser; Adrian G Barnett; Leslie P Johnson; Melinda G Wilson; Catherine M McHenry; Darren L Walters; Christopher R Warnholtz; Frederick A Khafagi
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

3.  Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo.

Authors:  J T Larsen; L L Hansen; K Brosen
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 4.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

Review 5.  Impact of Energy Drinks on Health and Well-being.

Authors:  Senthilkumar Sankararaman; Wahid Syed; Valentina Medici; Thomas J Sferra
Journal:  Curr Nutr Rep       Date:  2018-09

6.  Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination.

Authors:  A Balogh; G Klinger; L Henschel; A Börner; R Vollanth; W Kuhnz
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  On the relation between standard deviation and arithmetic mean in pharmacokinetic studies.

Authors:  H J Koch
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  Parkinson's disease and CYP1A2 activity.

Authors:  J T Forsyth; R A Grünewald; A Rostami-Hodjegan; M S Lennard; H J Sagar; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

9.  PK-DB: pharmacokinetics database for individualized and stratified computational modeling.

Authors:  Jan Grzegorzewski; Janosch Brandhorst; Kathleen Green; Dimitra Eleftheriadou; Yannick Duport; Florian Barthorscht; Adrian Köller; Danny Yu Jia Ke; Sara De Angelis; Matthias König
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

10.  Acute effects of light and dark roasted coffee on glucose tolerance: a randomized, controlled crossover trial in healthy volunteers.

Authors:  Elin Rakvaag; Lars Ove Dragsted
Journal:  Eur J Nutr       Date:  2015-09-05       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.